Production (Stage)
Indaptus Therapeutics, Inc.
INDP
$0.3426
-$0.0007-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.53M | -4.13M | -3.07M | -4.02M | -3.81M |
| Total Depreciation and Amortization | -- | 0.00 | 0.00 | 0.00 | 700.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 240.90K | 304.10K | 444.20K | 782.90K | 774.70K |
| Change in Net Operating Assets | -755.60K | 431.20K | 111.80K | 754.50K | -905.20K |
| Cash from Operations | -5.05M | -3.40M | -2.51M | -2.48M | -3.94M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.48M | 2.14M | 3.00M | 39.50K | 336.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -331.30K | -333.20K | -408.00K | -1.50K | -20.00K |
| Cash from Financing | 3.15M | 1.80M | 2.59M | 38.10K | 316.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.90M | -1.59M | 78.90K | -2.44M | -3.62M |